Right Heart Failure Clinical Trials

7 recruiting

Frequently Asked Questions

Common questions about Right Heart Failure clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Incidence and Evolution of Heart-lung Interaction in Acute Respiratory Distress Syndrome

Right Heart FailureAcute Respiratory Distress Syndrome
Bicetre Hospital500 enrolled1 locationNCT07450846
Recruiting

Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure

Pulmonary HypertensionHeart Failure With Reduced Ejection FractionRight Heart Failure Due to Left Heart Failure
Johns Hopkins University50 enrolled1 locationNCT06299436
Recruiting

Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

HypertensionStrokeInfections+5 more
International Consortium of Circulatory Assist Clinicians150 enrolled7 locationsNCT06039176
Recruiting
Phase 2

Feasibility Trial for a Right Ventricular Failure Platform Trial

Pulmonary HypertensionRight Ventricular DysfunctionRight Heart Failure
University of Alberta30 enrolled5 locationsNCT06570473
Recruiting

Cholate Clearance in Fontan and Heart Failure

Right Heart FailureFontan
HepQuant, LLC75 enrolled1 locationNCT07009132
Recruiting
Phase 2

Repurposing Valsartan May Protect Against Pulmonary Hypertension

Pulmonary Arterial HypertensionRight Ventricular DysfunctionRight Heart Failure+1 more
University of Washington60 enrolled1 locationNCT06053580
Recruiting

Right Ventricular Pressure Waveform Monitoring in Cardiac Surgery

Congestive Heart FailureRight Ventricular DysfunctionRight Heart Failure
Montreal Heart Institute112 enrolled1 locationNCT04092855
Recruiting

Pforzheim Tricuspid Valve Registry - Outcomes of Percutaneous Tricuspid Valve Repair

Tricuspid RegurgitationRight Heart FailureCardiac Remodeling, Ventricular+1 more
Helios Klinikum Pforzheim200 enrolled1 locationNCT05179616